Working… Menu

Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00428935
Recruitment Status : Completed
First Posted : January 30, 2007
Last Update Posted : February 5, 2013
Asklepios Biopharmaceutical, Inc.
Information provided by (Responsible Party):
Jerry R. Mendell, Nationwide Children's Hospital